AGT and cardiac hypertrophy: IRMI infusion of QC-13 or SnMP in Ang II treated mice resulted in further increases in cardiac hypertrophy as compared to Ang II treated mice alone with heart weight to body weight ratios averaging 6.4 ± 0.6 and 7.6 ± 0.6 mg/g in each group, respectively (Figure 1(b)).